Agape ATP Corporation (NASDAQ:ATPC - Get Free Report) was the recipient of a large decrease in short interest in August. As of August 31st, there was short interest totaling 3,500 shares, a decrease of 93.5% from the August 15th total of 54,000 shares. Based on an average daily volume of 46,200 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the stock are sold short. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 46,200 shares, the days-to-cover ratio is presently 0.1 days.
Agape ATP Price Performance
ATPC traded up $0.02 during midday trading on Tuesday, reaching $1.30. 4,607 shares of the company's stock traded hands, compared to its average volume of 1,285,530. Agape ATP has a 52 week low of $0.90 and a 52 week high of $2.93. The firm has a fifty day moving average of $1.34 and a two-hundred day moving average of $1.48. The stock has a market capitalization of $65.01 million, a price-to-earnings ratio of -3.17 and a beta of -0.98.
Agape ATP (NASDAQ:ATPC - Get Free Report) last posted its earnings results on Wednesday, August 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. Agape ATP had a negative net margin of 183.13% and a negative return on equity of 20.32%.
Analyst Ratings Changes
Separately, Wall Street Zen upgraded shares of Agape ATP from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd.
Get Our Latest Research Report on Agape ATP
About Agape ATP
(
Get Free Report)
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names.
Further Reading
Before you consider Agape ATP, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agape ATP wasn't on the list.
While Agape ATP currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.